Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Capitol Capsule: Lack of R&D investment could drive US innovation overseas, White House panel says

This article was originally published in Scrip

Executive Summary

As the political theater continued last week in Washington over how to avert the fiscal cliff – the convergence in January of the end of the Bush-era tax breaks and the start of the $1 trillion across-the-board sequestration cuts to federal agencies and programs – a presidential advisory panel warned that if bold investments are not made in US research, the growing threat to the nation's leadership role in science, technology and innovation will only heighten, harming the American economy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC019624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel